Skip to main content
LDXC
OTC Technology

Londax Corp. Discloses Going Concern Doubt, Ineffective Controls, and Significant Losses in Q3 Report

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
9
Price
$3.5
Mkt Cap
0
52W Low
$0.25
52W High
$3.635
Market data snapshot near publication time

Summary

Londax Corp.'s latest 10-Q reveals substantial doubt about its ability to continue as a going concern, ineffective internal controls, and a significant year-over-year revenue decline and net loss, despite a one-time debt forgiveness.


Key Events

  • Going Concern Warning Issued

    Management explicitly states 'substantial doubt' about the company's ability to continue as a going concern due to accumulated losses of $36,368 and a net loss of $33,089 for the nine months ended February 28, 2026.

  • Ineffective Internal Controls Disclosed

    Management concluded that disclosure controls and procedures were not effective as of February 28, 2026, indicating a material weakness in financial reporting oversight.

  • Significant Financial Deterioration

    The company reported a 70% year-over-year revenue decrease and a 238% increase in net loss for the nine months ended February 28, 2026, primarily due to a shift in revenue model and increased operating expenses.

  • Increased Reliance on Related Party Funding

    A related party loan from the president increased significantly to $49,485, providing critical working capital but highlighting dependence on insider financing, with no formal agreement for future support.


Analysis

This quarterly report highlights severe financial distress and operational weaknesses for Londax Corp. The explicit 'going concern' warning, coupled with a substantial year-over-year revenue decline and net loss, indicates a precarious financial position. The disclosure of ineffective internal controls further raises concerns about the company's governance and ability to accurately report financial information. While a related party loan provides some short-term liquidity, the heavy reliance on such funding and the lack of a formal agreement for future support from the former president underscore the company's vulnerability. Investors should be aware of the significant risks to the company's viability and the potential for further dilution if it attempts to raise capital.

At the time of this filing, LDXC was trading at $3.50 on OTC in the Technology sector. The 52-week trading range was $0.25 to $3.64. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LDXC - Latest Insights

LDXC
Apr 07, 2026, 8:27 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.50
Real-time Price: $1.50 info
Change: -$2.00 (-57%) info
Market Cap: N/A info